Nektar Therapeutics
NKTR
#4160
Rank
HK$22.85 B
Marketcap
HK$677.35
Share price
1.67%
Change (1 day)
676.85%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): -HK$33.12

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$33.14. In 2024 the company made an earnings per share (EPS) of -HK$27.42 an increase over its 2023 EPS that were of -HK$171.57.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$33.1220.78%
2024-HK$27.42-84.02%
2023-HK$171.57-25.89%
2022-HK$231.50-31.12%
2021-HK$336.0914.86%
2020-HK$292.61-1.19%
2019-HK$296.14-163.96%
2018HK$463.01-725.4%
2017-HK$74.03-42.73%
2016-HK$129.2783.33%
2015-HK$70.5139.53%
2014-HK$50.53-69.29%
2013-HK$164.52-6.67%
2012-HK$176.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.26-363.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$10.65-132.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$112.27-438.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-HK$14.49-56.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$57.27-272.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$46.46-240.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
HK$0.55-101.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
HK$16.22-148.94%๐Ÿ‡ฎ๐Ÿ‡ช Ireland